Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Aisling Capital II LP — INTERPHARM HOLDINGS INC insider · InsiderLens

Home / Insiders / Aisling Capital II LP

Aisling Capital II LP

See Footnote 1 at INTERPHARM HOLDINGS INC · on record since Nov 19, 2007
10% owner at INTERPHARM HOLDINGS INC · on record since Mar 3, 2008
10% owner at R&R ACQUISITION VI, INC · on record since Feb 16, 2012
10% owner at CEMPRA, INC. · on record since Feb 9, 2012
10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
10% owner at Cidara Therapeutics, Inc. · on record since Apr 14, 2015
10% owner at ViewRay, Inc. · on record since Mar 30, 2016

Insider trading activity of Aisling Capital II LP

No transactions on record for Aisling Capital II LP.

Track record of Aisling Capital II LP

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Aisling Capital II LP

Co-insiders of Aisling Capital II LP

AISLING CAPITAL PARTNERS LLCCEMPRA, INC. +5
AISLING CAPITAL PARTNERS, LPCEMPRA, INC. +5
ELMS STEVECEMPRA, INC. +5
Purcell Dennis JCEMPRA, INC. +5
SCHIFF ANDREW NCEMPRA, INC. +5
GOLDSTEIN DOV A MDCEMPRA, INC. +2
BB BIOTECH AGCidara Therapeutics, Inc. +1
BIOTECH TARGET N V

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Cidara Therapeutics, Inc. +1

5AM Co-Investors III, L.P.Cidara Therapeutics, Inc.

5AM VENTURES III, L.P.Cidara Therapeutics, Inc.

Abdollahian NeilCidara Therapeutics, Inc.

Alecxih JamesViewRay, Inc.

Alta Partners Management VIII, LLCEsperion Therapeutics, Inc.

Alta Partners VIII, L.P.Esperion Therapeutics, Inc.

BANSAL AJAYViewRay, Inc.

Bartizal KenCidara Therapeutics, Inc.

Bartram RichardEsperion Therapeutics, Inc.

Bassler Bonnie LCidara Therapeutics, Inc.

BAYH SUSAN BEsperion Therapeutics, Inc.

Berkowitz JeffreyEsperion Therapeutics, Inc.

Berlent JonathanINTERPHARM HOLDINGS INC

BHUTANI PRAVEENINTERPHARM HOLDINGS INC

Bilenker Joshua H.ViewRay, Inc.

Biotest AGR&R ACQUISITION VI, INC

Biotest Divestiture TrustR&R ACQUISITION VI, INC

Biotest Pharmaceuticals CorpR&R ACQUISITION VI, INC

BLAIR HENRY EEsperion Therapeutics, Inc.

BLAIR JAMES CEsperion Therapeutics, Inc.

Blum SusanCEMPRA, INC.

Bluth John DCEMPRA, INC.

Bonita David PViewRay, Inc.

Boxer Asset Management Inc.Esperion Therapeutics, Inc.

Boxer Capital, LLCEsperion Therapeutics, Inc.

Brandt MichaelViewRay, Inc.

Braslyn Ltd.Esperion Therapeutics, Inc.

Braunstein ScottEsperion Therapeutics, Inc.

BRINKERHOFF WILLIAM FEsperion Therapeutics, Inc.

Buono TimothyINTERPHARM HOLDINGS INC

BURGESS DANIEL DCidara Therapeutics, Inc.

Burke Willaim PViewRay, Inc.

Burrill Capital Fund IV, L.P.R&R ACQUISITION VI, INC

Burrill & Co (BCF IV GP), LLCR&R ACQUISITION VI, INC

BURRILL STEVENR&R ACQUISITION VI, INC

Cammarata SueCEMPRA, INC.

Canale-Theakston CarinCidara Therapeutics, Inc.

Cappel KennethINTERPHARM HOLDINGS INC

CARROLL J MARTINEsperion Therapeutics, Inc.

Castelein CaleyViewRay, Inc.

CHAMPSI FARAHEsperion Therapeutics, Inc.

Chandler D. DavidViewRay, Inc.

No transactions on record. Reset filters